News
LIB takes aim at cholesterol market with new PCSK9 option
LIB Therapeutics has won FDA approval for a once-monthly cholesterol drug, Lerochol, that it says offers ease-of-use advantages over rivals.
News
UK, US approve GSK's twice-yearly asthma drug
GSK scores a first approval in the UK for new severe asthma and CRSwNP therapy Exdensur, but a second in the US covers the asthma indication only.
News
CDC signs off on advice ending universal hepatitis B jabs
Overturning decades of advice, the CDC has said it no longer recommends that all US newborns receive a hepatitis B vaccine.
News
Allergy Tx plots grass pollen jab launch after German okay
Allergy Therapeutics has had its grass pollen allergy treatment Grassmuno approved in Germany, its first market, setting up a launch early next year.
News
Prof Jonathan Benger named as NICE's new CEO
Prof Jonathan Benger will take over from Dr Sam Roberts as CEO of UK reimbursement authority NICE later this week, at a critical time for the agency.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
